FDA MedWatch News

• FDA Recommends Transition from Use of Decontaminated Disposable Respirators - Letter to Health Care Personnel and Facilities
  Source: FDA Published on 2021-04-09
• Medtronic Recalls Valiant Navion Thoracic Stent Graft System Due to Risk of Stent Fractures and Type III Endoleaks
  Source: FDA Published on 2021-04-09
• NS NY Distributor Inc Issues Voluntary Nationwide Recall of Premium OrgaZen 7000 and Ginseng Power 5000 Due to Presence of Undeclared Sildenafil and/or Tadalafil
  Source: FDA Published on 2021-04-09
• Yolo Studio Issues Voluntary Nationwide Recall of PremierZEN Extreme 3000, PremierZEN Plus 5000, & Triple SupremeZEN Plus 3500 Due to the Presence of Undeclared Tadalafil
  Source: FDA Published on 2021-04-06
• Yolo Studio Issues Voluntary Nationwide Recall of PremierZEN Extreme 3000, PremierZEN Black 5000, & Triple SupremeZEN Plus 3500 Due to the Presence of Undeclared Tadalafil
  Source: FDA Published on 2021-04-06
• QMART Issues Voluntary Nationwide Recall of IMPERIAL Gold 2000, PremierZEN Extreme 3000, BURRO en PRIMAVERA 60000 & IMPERIAL Platinum 2000 Due to Presence of Undeclared Sildenafil and/or Tadalafil
  Source: FDA Published on 2021-04-05
• A-S Medication Solutions Issues Voluntary Nationwide Recall of Acetaminophen Extra Strength Tablets Contained in Health Essentials Kits Due to Mislabeling
  Source: FDA Published on 2021-04-02
• Infections Associated with Reprocessed Urological Endoscopes - Letter to Health Care Providers
  Source: FDA Published on 2021-04-01
• Ummzy LLC Issues Voluntary Nationwide Recall of Thumbs up 7 Red 70K, Shogun-X 15000mg, and Krazy Night Due to the Presence of Undeclared Tadalafil Sildenafil & Vardenafil
  Source: FDA Published on 2021-03-31
• Nuri Trading LLC Issues Voluntary Nationwide Recall of Shogun-X 7000, Thumbs Up 7 (Black) 25K, Thumbs Up 7 (White) 11K, 69MODE Blue 69, Due to the Presence of Undeclared Tadalafil, Sildenafil, and/ or Vardenafil
  Source: FDA Published on 2021-03-31
• Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction Differ in Complication Rates: FDA Safety Communication
  Source: FDA Published on 2021-03-31
• Lamictal (lamotrigine): Drug Safety Communication - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease
  Source: FDA Published on 2021-03-31
• Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended-Release Tablets 2mg Due to Trace Amounts of Quetiapine Fumarate
  Source: FDA Published on 2021-03-31
• Bit & Bet LLC Issues Voluntary Nationwide Recall of Thumbs Up 7 Blue 69K Due to Presence of Undeclared Sildenafil and Tadalafil
  Source: FDA Published on 2021-03-30
• Mammography Problems at Tennessee Women’s Care P.C. in Nashville, TN: FDA Safety Communication
  Source: FDA Published on 2021-03-30

Share this:

• Twitter
• LinkedIn
• Facebook